Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dr. Hoenle AG ( (DE:HNL) ) has provided an announcement.
Hoenle AG has announced that it will publish its consolidated half-year report for the 2025/26 financial year on 19 May 2026. The report will cover the period from 1 October 2025 to 31 March 2026 and will be made available on the company’s investor relations website.
By pre-announcing the publication date of its half-year figures, Hoenle AG provides investors and analysts with clarity on its upcoming financial disclosure schedule. This transparency supports planning for market participants who closely track the company’s performance and valuation across the German stock exchanges where its shares are traded.
The most recent analyst rating on (DE:HNL) stock is a Hold with a EUR9.00 price target. To see the full list of analyst forecasts on Dr. Hoenle AG stock, see the DE:HNL Stock Forecast page.
More about Dr. Hoenle AG
Hoenle AG is a Germany-based company listed on the regulated market in Frankfurt and several regional exchanges. The group operates internationally, serving industrial clients with technologies and solutions typically associated with specialized engineering and manufacturing sectors, and targets a broad investor base through its capital market presence.
Average Trading Volume: 5,565
Technical Sentiment Signal: Hold
Current Market Cap: €56.98M
Find detailed analytics on HNL stock on TipRanks’ Stock Analysis page.